Teva Pharmaceutical Industries (TEVA) Return on Capital Employed: 2009-2025
Historic Return on Capital Employed for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to 0.06%.
- Teva Pharmaceutical Industries' Return on Capital Employed rose 5.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 5.00%. This contributed to the annual value of -0.01% for FY2024, which is 2.00% down from last year.
- Latest data reveals that Teva Pharmaceutical Industries reported Return on Capital Employed of 0.06% as of Q3 2025, which was up 96.54% from 0.03% recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Return on Capital Employed registered a high of 0.06% during Q3 2025, and its lowest value of -0.09% during Q1 2021.
- Over the past 3 years, Teva Pharmaceutical Industries' median Return on Capital Employed value was 0.01% (recorded in 2023), while the average stood at 0.00%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first rose by 15bps in 2021, then dropped by 11bps in 2022.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Return on Capital Employed stood at 0.05% in 2021, then declined by 11bps to -0.07% in 2022, then rose by 8bps to 0.01% in 2023, then fell by 3bps to -0.01% in 2024, then climbed by 5bps to 0.06% in 2025.
- Its last three reported values are 0.06% in Q3 2025, 0.03% for Q2 2025, and 0.02% during Q1 2025.